Genetic Susceptibility and Biomarkers of Platinum-Related Toxicities
L
Lawrence Einhorn, MD
Primary Investigator
M
Mary Brames
Primary Investigator
Overview
The purpose of this study is to look at the long term health of men who have been treated for a germ cell tumor with cisplatin chemotherapy.
Description
The purpose of this study is to look at the long term health of men who have been treated for a germ cell tumor with cisplatin chemotherapy.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Testicular Cancer
-
Age: Between 18 Years - 100 Years
-
Gender: Male
Inclusion Criteria
Diagnosed with testicular cancer
Diagnosed at age 49 or younger
Participants may be paid for their participation.
Updated on
23 Apr 2024.
Study ID: 1305011509 (RSRB45410)